Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;120(10):1042-1044.
doi: 10.1007/s00347-023-01808-6. Epub 2023 Feb 1.

[Pembrolizumab (Keytruda®) associated ocular hypotony]

[Article in German]
Affiliations

[Pembrolizumab (Keytruda®) associated ocular hypotony]

[Article in German]
S Dierse et al. Ophthalmologie. 2023 Oct.
No abstract available

PubMed Disclaimer

References

Literatur

    1. Roberts K, Culleton V, Lwin Z, O’Byrne K, Hughes BG (2017) Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities. Asia Pac J Clin Oncol 13(4):277–288. https://doi.org/10.1111/ajco.12698 - DOI - PubMed
    1. Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA (2018) Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects. Retina 38(6):1063–1078. https://doi.org/10.1097/iae.0000000000002181 - DOI - PubMed
    1. https://www.ema.europa.eu/en/documents/product-information/keytruda-epar... . Zugegriffen: 15. Dez. 2022
    1. Mihailovic N, Dyballa J, Herz S, Fluck M, Alnawaiseh M, Merté RL, Eter N (2020) Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma. Ophthalmologe 117(5):467–471. https://doi.org/10.1007/s00347-019-00963-z - DOI - PubMed
    1. Wang Q, Thau A, Levin AV, Lee D (2019) Surv ocular hypotony: a comprehensive review. Surv Ophthalmol 64(5):619–638. https://doi.org/10.1016/j.survophthal.2019.04.006 - DOI - PubMed